iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, and the Pink Lotus Breast Center in Beverly Hills, California, announced an agreement that will make the Xoft® Axxent® Electronic Brachytherapy System® available to breast cancer patients treated at Pink Lotus. The Xoft system for Intraoperative Radiation Therapy (IORT) delivers a single, prescribed, targeted dose of radiation during surgery directly to the tumor cavity – minimizing radiation to healthy tissue and organs. The announcement was made during the annual meeting of the American Society of Breast Surgeons in Phoenix, where iCAD is showcasing the Xoft system.
“By adopting the Xoft system for IORT we can now offer our patients the option of receiving a full dose of radiation therapy in the operating room during their lumpectomy, allowing minimal disruption to our patients’ active lives,” said Kristi Funk, MD, Founder, Pink Lotus Breast Center. “At Pink Lotus we are committed to providing our patients with cutting-edge treatment options that improve care. By offering the Xoft system, we are giving our patients access to an innovative radiation therapy option that is highly effective and more convenient while minimizing radiation exposure.”
“The increasing adoption of the Xoft system by leading radiation oncologists as well as breast surgeons like Dr. Kristi Funk, across the nation and around the globe, highlights the growing demand for IORT,” said Ken Ferry, President and CEO of iCAD. “We are excited to be working with the Pink Lotus Breast Center, which is a nationally recognized thought leader at the forefront of breast cancer detection and treatment.”
As the Xoft system does not require a shielded environment, and is relatively small in size, it can easily be transported for use in virtually any clinical setting (including the operating room where IORT is delivered) under radiation oncology supervision. The Xoft system may also be used for accelerated partial breast irradiation (APBI), which can be delivered twice daily for five days.